Curcumin in various cancers - PubMed (original) (raw)

Review

. 2013 Jan-Feb;39(1):56-68.

doi: 10.1002/biof.1068. Epub 2013 Jan 10.

Affiliations

• PMID: 23303705
• DOI: 10.1002/biof.1068

Review

Curcumin in various cancers

Adeeb Shehzad et al. Biofactors. 2013 Jan-Feb.

Abstract

Curcumin (diferuloylmethane), an active constituent of turmeric, is a well-described phytochemical, which has been used since ancient times for the treatment of various diseases. The dysregulation of cell signaling pathways by the gradual alteration of regulatory proteins is the root cause of cancers. Curcumin modulates regulatory proteins through various molecular mechanisms. Several research studies have provided in-depth analysis of multiple targets through which curcumin induces protective effects against cancers including gastrointestinal, genitourinary, gynecological, hematological, pulmonary, thymic, brain, breast, and bone. The molecular mechanisms of action of curcumin in treating different types of cancers remain under investigation. The multifaceted role of this dietary agent is mediated through its inhibition of several cell signaling pathways at multiple levels. Curcumin has the ability to inhibit carcinogenicity through the modulation of the cell cycle by binding directly and indirectly to molecular targets including transcription factors (NF-kB, STAT3, β-catenin, and AP-1), growth factors (EGF, PDGF, and VEGF), enzymes (COX-2, iNOS, and MMPs), kinases (cyclin D1, CDKs, Akt, PKC, and AMPK), inflammatory cytokines (TNF, MCP, IL-1, and IL-6), upregulation of proapoptotic (Bax, Bad, and Bak) and downregulation of antiapoptotic proteins (Bcl(2) and Bcl-xL). A variety of animal models and human studies have proven that curcumin is safe and well tolerated even at very high doses. This study elaborates the current understanding of the chemopreventive effects of curcumin through its multiple molecular pathways and highlights its therapeutic value in the treatment and prevention of a wide range of cancers.

Copyright © 2013 International Union of Biochemistry and Molecular Biology, Inc.

PubMed Disclaimer

Similar articles

• Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials.
  Shehzad A, Wahid F, Lee YS. Shehzad A, et al. Arch Pharm (Weinheim). 2010 Sep;343(9):489-99. doi: 10.1002/ardp.200900319. Arch Pharm (Weinheim). 2010. PMID: 20726007 Review.
• Molecular mechanisms of curcumin action: gene expression.
  Shishodia S. Shishodia S. Biofactors. 2013 Jan-Feb;39(1):37-55. doi: 10.1002/biof.1041. Epub 2012 Sep 20. Biofactors. 2013. PMID: 22996381 Review.
• Curcumin and cancer: an "old-age" disease with an "age-old" solution.
  Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Anand P, et al. Cancer Lett. 2008 Aug 18;267(1):133-64. doi: 10.1016/j.canlet.2008.03.025. Epub 2008 May 6. Cancer Lett. 2008. PMID: 18462866 Review.
• Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
  Kunnumakkara AB, Anand P, Aggarwal BB. Kunnumakkara AB, et al. Cancer Lett. 2008 Oct 8;269(2):199-225. doi: 10.1016/j.canlet.2008.03.009. Epub 2008 May 13. Cancer Lett. 2008. PMID: 18479807 Review.
• Molecular mechanisms of curcumin action: signal transduction.
  Shehzad A, Lee YS. Shehzad A, et al. Biofactors. 2013 Jan-Feb;39(1):27-36. doi: 10.1002/biof.1065. Epub 2013 Jan 10. Biofactors. 2013. PMID: 23303697 Review.

Cited by

• The multifaceted role of curcumin in cancer prevention and treatment.
  Shanmugam MK, Rane G, Kanchi MM, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Tan BK, Kumar AP, Sethi G. Shanmugam MK, et al. Molecules. 2015 Feb 5;20(2):2728-69. doi: 10.3390/molecules20022728. Molecules. 2015. PMID: 25665066 Free PMC article. Review.
• Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway.
  Vallée A, Lecarpentier Y, Vallée JN. Vallée A, et al. J Exp Clin Cancer Res. 2019 Jul 22;38(1):323. doi: 10.1186/s13046-019-1320-y. J Exp Clin Cancer Res. 2019. PMID: 31331376 Free PMC article. Review.
• Cruciferous vegetables as a treasure of functional foods bioactive compounds: Targeting p53 family in gastrointestinal tract and associated cancers.
  Mitra S, Emran TB, Chandran D, Zidan BMRM, Das R, Mamada SS, Masyita A, Salampe M, Nainu F, Khandaker MU, Idris AM, Simal-Gandara J. Mitra S, et al. Front Nutr. 2022 Aug 4;9:951935. doi: 10.3389/fnut.2022.951935. eCollection 2022. Front Nutr. 2022. PMID: 35990357 Free PMC article. Review.
• The critical roles of miR-21 in anti-cancer effects of curcumin.
  Chen J, Xu T, Chen C. Chen J, et al. Ann Transl Med. 2015 Dec;3(21):330. doi: 10.3978/j.issn.2305-5839.2015.09.20. Ann Transl Med. 2015. PMID: 26734640 Free PMC article. Review.
• Synthesis, evaluation of cytotoxic properties of promising curcumin analogues and investigation of possible molecular mechanisms.
  Jordan BC, Kumar B, Thilagavathi R, Yadhav A, Kumar P, Selvam C. Jordan BC, et al. Chem Biol Drug Des. 2018 Jan;91(1):332-337. doi: 10.1111/cbdd.13061. Epub 2017 Jul 18. Chem Biol Drug Des. 2018. PMID: 28649799 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • scite Smart Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal